SKAN-MEDIC ApS: Financial statements 2023
CVR: 89890411
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
SKAN-MEDIC ApS (CVR 89890411) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,555,762 and a net result of DKK 2,018,755 compared with DKK 1,414,472 the year before. That is an increase of 19.7% compared with the year before. Equity in the 2023 report amounted to DKK 5,358,335. The solvency ratio was 87.5%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,555,762
- Profit/Loss
- DKK 2,018,755
- Equity
- DKK 5,358,335
- Total Assets
- DKK 6,125,047
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.6 mio. | 2 mio. | 5.4 mio. | 4 |
| 2022 | - | 2.1 mio. | 1.4 mio. | 4.8 mio. | 5 |
| 2021 | - | 2 mio. | 6.6 mio. | 15.4 mio. | 6 |
| 2020 | - | 2.6 mio. | 3 mio. | 10.8 mio. | 5 |
| 2019 | - | 2.1 mio. | 2.6 mio. | 7.8 mio. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
SKAN-MEDIC ApS has published its annual report for 2022. Gross profit came to DKK 2,134,717, and the net result was DKK 1,414,472.
As of May 25, 2023, Susanne Rasmussen is registered as director of SKAN-MEDIC ApS.
As of May 25, 2023, Aage Rasmussen has stepped down as director of SKAN-MEDIC ApS.
About SKAN-MEDIC ApS
SKAN-MEDIC ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1982. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named LAGENULA ApS. The management consists of Line Wulff. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,452,548 and a net result of DKK 989,847 compared with DKK 1,891,452 the year before. Equity in the 2025 report amounted to DKK 3,239,634.